{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:46:58Z","timestamp":1767134818822,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":130,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd002190.pub4","type":"reference-entry","created":{"date-parts":[[2013,6,11]],"date-time":"2013-06-11T21:13:10Z","timestamp":1370985190000},"source":"Crossref","is-referenced-by-count":3,"title":["Vaccines for the common cold"],"prefix":"10.1002","author":[{"given":"Daniel","family":"Simancas-Racines","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia V","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo","family":"Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,6,12]]},"reference":[{"issue":"6","key":"10.1002\/14651858.CD002190.pub4-BIB1|cit1","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/archinte.1970.00310060059005","article-title":"Live and inactivated adenovirus vaccines. Clinical evaluation of efficacy in prevention of acute respiratory disease","volume":"125","author":"Griffin","year":"1970","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub4-BIB2|cit2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/infdis\/145.3.311","article-title":"Parenteral administration of live respiratory syncytial virus vaccine: results of a field trial","volume":"145","author":"Belshe","year":"1982","journal-title":"Journal of Infectious Diseases"},{"issue":"8","key":"10.1002\/14651858.CD002190.pub4-BIB3|cit3","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1128\/JCM.30.8.2064-2070.1992","article-title":"Evaluation of a live attenuated, cold-adapted parainfluenza virus type 3 vaccine in children","volume":"30","author":"Belshe","year":"1992","journal-title":"Journal of Clinical Microbiology"},{"issue":"12","key":"10.1002\/14651858.CD002190.pub4-BIB4|cit4","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1086\/425981","article-title":"Evaluation of combined live, attenuated respiratory syncytial virus and parainfluenza 3 virus vaccines in infants and young children","volume":"190","author":"Belshe","year":"2004","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub4-BIB5|cit5","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1086\/381184","article-title":"Phase 2 evaluation of parainfluenza type 3 cold passage mutant 45 live attenuated vaccine in healthy children 6-18 months old","volume":"189","author":"Belshe","year":"2004","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub4-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1128\/JCM.29.6.1175-1182.1991","article-title":"Evaluation of bovine, cold-adapted human, and wild-type human parainfluenza type 3 viruses in adult volunteers and in chimpanzees","volume":"29","author":"Clements","year":"1991","journal-title":"Journal of Clinical Microbiology"},{"issue":"19","key":"10.1002\/14651858.CD002190.pub4-BIB7|cit7","doi-asserted-by":"crossref","first-page":"8800","DOI":"10.1073\/pnas.0912186107","article-title":"A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus","volume":"107","author":"DeVincenzo","year":"2010","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"5322","key":"10.1002\/14651858.CD002190.pub4-BIB8|cit8","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1136\/bmj.1.5322.34","article-title":"Some attempts to produce an experimental vaccine with rhinoviruses","volume":"1","author":"Doggett","year":"1963","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub4-BIB9|cit9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1128\/IAI.5.3.295-299.1972","article-title":"Enteric immunization with live adenovirus type 21 vaccine. I. Tests for safety, infectivity, immunogenicity, and potency in volunteers","volume":"5","author":"Dudding","year":"1972","journal-title":"Infection and Immunity"},{"issue":"13","key":"10.1002\/14651858.CD002190.pub4-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/S0264-410X(96)00030-8","article-title":"Safety and immunogenicity of a respiratory syncytial virus subunit vaccine (PFP-2) in ambulatory adults over age 60","volume":"14","author":"Falsey","year":"1996","journal-title":"Vaccine"},{"issue":"9","key":"10.1002\/14651858.CD002190.pub4-BIB11|cit11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1086\/592168","article-title":"Comparison of the safety and immunogenicity of 2 respiratory syncytial virus (rsv) vaccines--nonadjuvanted vaccine or vaccine adjuvanted with alum--given concomitantly with influenza vaccine to high-risk elderly individuals","volume":"198","author":"Falsey","year":"2008","journal-title":"Journal of Infectious Diseases"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub4-BIB12|cit12","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1093\/oxfordjournals.aje.a120956","article-title":"Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine","volume":"89","author":"Fulginiti","year":"1969","journal-title":"American Journal of Epidemiology"},{"issue":"7","key":"10.1002\/14651858.CD002190.pub4-BIB13|cit13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/INF.0b013e318199c3b1","article-title":"Phase-I study MEDI-534, of a live, attenuated intranasal vaccine against respiratory syncytial virus and parainfluenza-3 virus in seropositive children","volume":"28","author":"Gomez","year":"2009","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"17","key":"10.1002\/14651858.CD002190.pub4-BIB14|cit14","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/S0264-410X(99)00527-7","article-title":"Evaluation of the live attenuated cpts 248\/404 RSV vaccine in combination with a subunit RSV vaccine (PFP-2) in healthy young and older adults","volume":"18","author":"Gonzalez","year":"2000","journal-title":"Vaccine"},{"issue":"7","key":"10.1002\/14651858.CD002190.pub4-BIB15|cit15","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1086\/428092","article-title":"A bovine parainfluenza virus type 3 vaccine is safe and immunogenic in early infancy","volume":"191","author":"Greenberg","year":"2005","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub4-BIB16|cit16","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1093\/infdis\/132.6.623","article-title":"Human responses to two decavalent rhinovirus vaccines","volume":"132","author":"Hamory","year":"1975","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD002190.pub4-BIB17|cit17","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/infdis\/171.5.1107","article-title":"A live attenuated bovine parainfluenza virus type 3 vaccine is safe, infectious, immunogenic, and phenotypically stable in infants and children","volume":"171","author":"Karron","year":"1995","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub4-BIB18|cit18","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/infdis\/172.6.1445","article-title":"A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in healthy infants and children","volume":"172","author":"Karron","year":"1995","journal-title":"Journal of Infectious Diseases"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub4-BIB19|cit19","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1086\/514138","article-title":"Evaluation of two live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccines in chimpanzees and in human adults, infants, and children","volume":"176","author":"Karron","year":"1997","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD002190.pub4-BIB20|cit20","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/01.inf.0000066244.31769.83","article-title":"A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants","volume":"22","author":"Karron","year":"2003","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"7","key":"10.1002\/14651858.CD002190.pub4-BIB21|cit21","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1086\/427813","article-title":"Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants","volume":"191","author":"Karron","year":"2005","journal-title":"Journal of Infectious Diseases"},{"issue":"42","key":"10.1002\/14651858.CD002190.pub4-BIB22|cit22","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1016\/j.vaccine.2009.07.038","article-title":"A dose-ranging study of a subunit Respiratory Syncytial Virus subtype A vaccine with and without aluminum phosphate adjuvantation in adults > or =65 years of age","volume":"27","author":"Langley","year":"2009","journal-title":"Vaccine"},{"issue":"7","key":"10.1002\/14651858.CD002190.pub4-BIB23|cit23","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1086\/323150","article-title":"Antibody responses to bovine parainfluenza virus type 3 (PIV3) vaccination and human PIV3 infection in young infants","volume":"184","author":"Lee","year":"2001","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub4-BIB24|cit24","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.antiviral.2004.04.005","article-title":"Experimental infection of humans with A2 respiratory syncytial virus","volume":"63","author":"Lee","year":"2004","journal-title":"Antiviral Research"},{"issue":"7","key":"10.1002\/14651858.CD002190.pub4-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1177\/135965350701200702","article-title":"Safety and immunogenicity from a phase I trial of inactivated severe acute respiratory syndrome coronavirus vaccine","volume":"12","author":"Lin","year":"2007","journal-title":"Antiviral Therapy"},{"issue":"23","key":"10.1002\/14651858.CD002190.pub4-BIB26|cit26","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1016\/j.vaccine.2008.03.037","article-title":"A double-blind, placebo-controlled study of the safety and immunogenicity of live, oral type 4 and type 7 adenovirus vaccines in adults","volume":"26","author":"Lyons","year":"2008","journal-title":"Vaccine"},{"issue":"13","key":"10.1002\/14651858.CD002190.pub4-BIB27|cit27","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1016\/j.vaccine.2005.12.002","article-title":"Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers","volume":"24","author":"Madhi","year":"2006","journal-title":"Vaccine"},{"issue":"24","key":"10.1002\/14651858.CD002190.pub4-BIB28|cit28","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/S0264-410X(03)00352-9","article-title":"Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women","volume":"21","author":"Munoz","year":"2003","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD002190.pub4-BIB29|cit29","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0168-1702(94)90059-0","article-title":"An update on approaches to the development of respiratory syncytial virus (RSV) and parainfluenza virus type 3 (PIV3) vaccines","volume":"32","author":"Murphy","year":"1994","journal-title":"Virus Research"},{"issue":"9","key":"10.1002\/14651858.CD002190.pub4-BIB30|cit30","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1097\/00006454-199409000-00008","article-title":"Safety and immunogenicity of a subunit respiratory syncytial virus vaccine in children 24 to 48 months old","volume":"13","author":"Paradiso","year":"1994","journal-title":"Pediatric Infectious Disease Journal"},{"issue":"12","key":"10.1002\/14651858.CD002190.pub4-BIB31|cit31","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/0264-410X(95)00034-X","article-title":"Safety and immunogenicity of the PFP vaccine against respiratory syncytial virus (RSV): the western blot assay aids in distinguishing immune responses of the PFP vaccine from RSV infection","volume":"13","author":"Piedra","year":"1995","journal-title":"Vaccine"},{"issue":"1","key":"10.1002\/14651858.CD002190.pub4-BIB32|cit32","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/oxfordjournals.aje.a120805","article-title":"Live and inactivated adenovirus vaccines for the prevention of acute respiratory illness in naval recruits","volume":"87","author":"Pierce","year":"1968","journal-title":"American Journal of Epidemiology"},{"issue":"11","key":"10.1002\/14651858.CD002190.pub4-BIB33|cit33","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1086\/324426","article-title":"Safety and immunogenicity of a novel recombinant subunit respiratory syncytial virus vaccine (BBG2Na) in healthy young adults","volume":"184","author":"Power","year":"2001","journal-title":"Journal of Infectious Diseases"},{"issue":"7021","key":"10.1002\/14651858.CD002190.pub4-BIB34|cit34","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0140-6736(58)90870-5","article-title":"Autogenous vaccine in prophylaxis of the common cold","volume":"1","author":"Ritchie","year":"1958","journal-title":"Lancet"},{"issue":"5-6","key":"10.1002\/14651858.CD002190.pub4-BIB35|cit35","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S0264-410X(01)00388-7","article-title":"Respiratory syncytial virus vaccine: a systematic overview with emphasis on respiratory syncytial virus subunit vaccines","volume":"20","author":"Simoes","year":"2001","journal-title":"Vaccine"},{"issue":"50","key":"10.1002\/14651858.CD002190.pub4-BIB36|cit36","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1016\/j.vaccine.2008.09.018","article-title":"Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults","volume":"26","author":"Tang","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD002190.pub4-BIB37|cit37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1093\/infdis\/124.2.155","article-title":"Immunization with live types 7 and 4 adenovirus vaccines. II. Antibody response and protective effect against acute respiratory disease due to adenovirus type 7","volume":"124","author":"Top","year":"1971","journal-title":"Journal of Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD002190.pub4-BIB38|cit38","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/infdis\/167.1.191","article-title":"Immunogenicity and safety of respiratory syncytial virus subunit vaccine in seropositive children 18-36 months old","volume":"167","author":"Tristram","year":"1993","journal-title":"Journal of Infectious Diseases"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub4-BIB39|cit39","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0264-410X(90)90051-M","article-title":"Determinants of susceptibility to challenge and the antibody response of adult volunteers given experimental respiratory syncytial virus vaccines","volume":"8","author":"Watt","year":"1990","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD002190.pub4-BIB40|cit40","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/infdis\/170.2.425","article-title":"Respiratory syncytial virus-specific cell-mediated immune responses after vaccination with a purified fusion protein subunit vaccine","volume":"170","author":"Welliver","year":"1994","journal-title":"Journal of Infectious Diseases"},{"issue":"5179","key":"10.1002\/14651858.CD002190.pub4-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1136\/bmj.1.5179.1081","article-title":"Trial of adenovirus vaccine in Royal Air Force recruits","volume":"1","author":"Wilson","year":"1960","journal-title":"British Medical Journal"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub4-BIB42|cit42","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0022-3476(76)81044-X","article-title":"Evaluation of a live, attenuated respiratory syncytial virus vaccine in infants","volume":"88","author":"Wright","year":"1976","journal-title":"Journal of Pediatrics"},{"key":"10.1002\/14651858.CD002190.pub4-BIB43|cit43","article-title":"Glossary","volume-title":"Basic Immunology","volume":"1","author":"Abbas","year":"2001"},{"issue":"200","key":"10.1002\/14651858.CD002190.pub4-BIB44|cit44","first-page":"1","article-title":"Current estimates from the National Health Interview Survey 1996","volume":"10","author":"Adams","year":"1999","journal-title":"Vital Health Statistics"},{"issue":"7003","key":"10.1002\/14651858.CD002190.pub4-BIB45|cit45","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1136\/bmj.311.7003.485","article-title":"Absence of evidence is not evidence of absence","volume":"311","author":"Altman","year":"1995","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD002190.pub4-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/infdis\/171.1.1","article-title":"Protective and disease-enhancing immune responses to respiratory syncytial virus","volume":"171","author":"Anderson","year":"1995","journal-title":"Journal of Infectious Diseases"},{"issue":"15","key":"10.1002\/14651858.CD002190.pub4-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2012.466","article-title":"Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective","volume":"307","author":"Anonymous","year":"2012","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD002190.pub4-BIB48|cit48","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1128\/JCM.35.11.2864-2868.1997","article-title":"Frequency and natural history of rhinovirus infections in adults during autumn","volume":"35","author":"Arruda","year":"1997","journal-title":"Journal of Clinical Microbiology"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub4-BIB49|cit49","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD002190.pub4-BIB50|cit50","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.4049\/jimmunol.161.5.2473","article-title":"Subcellular site of expression and route of vaccination influence pulmonary eosinophilia following respiratory syncytial virus challenge in BALB\/c mice sensitized to the attachment G protein","volume":"161","author":"Bembridge","year":"1998","journal-title":"Journal of Immunology"},{"issue":"Suppl 6","key":"10.1002\/14651858.CD002190.pub4-BIB51|cit51","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/clinids\/13.Supplement_6.S454","article-title":"Epidemiology of acute respiratory infections in children of developing countries","volume":"13","author":"Berman","year":"1991","journal-title":"Reviews of Infectious Diseases"},{"issue":"10","key":"10.1002\/14651858.CD002190.pub4-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1086\/522969","article-title":"Emergence of adenovirus type 14 in US military recruits - a new challenge","volume":"196","author":"Binn","year":"2007","journal-title":"Journal of Infectious Diseases"},{"issue":"5","key":"10.1002\/14651858.CD002190.pub4-BIB53|cit53","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1398-9995.2010.02530.x","article-title":"Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations","volume":"66","author":"Brozek","year":"2011","journal-title":"Allergy"},{"key":"10.1002\/14651858.CD002190.pub4-BIB54|cit54","unstructured":"Division of Disease Control and Prevention Difference between cold and flu symptoms Utah Department of Health 2010 Available: http:\/\/health.utah.gov\/epi\/diseases\/flu\/ColdvsFlu.pdf"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub4-BIB55|cit55","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1542\/peds.71.6.871","article-title":"Croup: an 11 year study in a pediatric practice","volume":"71","author":"Denny","year":"1983","journal-title":"Pediatrics"},{"issue":"10","key":"10.1002\/14651858.CD002190.pub4-BIB56|cit56","doi-asserted-by":"crossref","first-page":"6298","DOI":"10.4049\/jimmunol.0713622","article-title":"A combination vaccine for allergy and rhinovirus infections based on rhinovirus-derived surface protein VP1 and a nonallergenic peptide of the major timothy grass pollen allergen PHl p1","volume":"182","author":"Edlmayr","year":"2009","journal-title":"Journal of Immunology"},{"issue":"2-4","key":"10.1002\/14651858.CD002190.pub4-BIB57|cit57","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/17402520600579168","article-title":"Towards a coronavirus-based HIV multigene vaccine","volume":"13","author":"Eriksson","year":"2006","journal-title":"Clinical and Developmental Immunology"},{"issue":"6 pt 1","key":"10.1002\/14651858.CD002190.pub4-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1542\/peds.111.6.1407","article-title":"Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children","volume":"111","author":"Esper","year":"2003","journal-title":"Pediatrics"},{"key":"10.1002\/14651858.CD002190.pub4-BIB59|cit59","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4899-0036-4","volume-title":"Viral Infection of Humans: Epidemiology and Control","author":"Evans","year":"1997"},{"issue":"17","key":"10.1002\/14651858.CD002190.pub4-BIB60|cit60","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1056\/NEJMoa043951","article-title":"Respiratory syncytial virus infection in elderly and high-risk adults","volume":"352","author":"Falsey","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002190.pub4-BIB61|cit61","unstructured":"Fermi Paradox www.crystalinks.com\/fermiparadox.html"},{"issue":"13","key":"10.1002\/14651858.CD002190.pub4-BIB62|cit62","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1056\/NEJM197809282991304","article-title":"The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 \"negative\" trials","volume":"299","author":"Freiman","year":"1978","journal-title":"New England Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD002190.pub4-BIB63|cit63","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1056\/NEJMp1207437","article-title":"Getting the methods right - the Foundation of Patient-Centered Outcomes Research","volume":"367","author":"Gabriel","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub4-BIB64|cit64","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.283.4.499","article-title":"Impact of respiratory infection on persons with chronic underlying conditions","volume":"283","author":"Glezen","year":"2000","journal-title":"JAMA"},{"key":"10.1002\/14651858.CD002190.pub4-BIB65|cit65","article-title":"Overview of the Immune system","volume-title":"Kuby Immunology","volume":"3","author":"Goldsby","year":"2000"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub4-BIB66|cit66","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1086\/322627","article-title":"Excessive antibiotic use for acute respiratory infections in the United States","volume":"33","author":"Gonzales","year":"2001","journal-title":"Clinical Infectious Diseases"},{"key":"10.1002\/14651858.CD002190.pub4-BIB67|cit67","article-title":"Inmmunolog\u00eda Tumoral","volume-title":"Inmunolog\u00eda Basada en problemas","volume":"138","author":"Gorczynski","year":"2007"},{"issue":"9","key":"10.1002\/14651858.CD002190.pub4-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1086\/522188","article-title":"Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006","volume":"45","author":"Gray","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"1","key":"10.1002\/14651858.CD002190.pub4-BIB69|cit69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/epirev\/24.1.4","article-title":"Design of randomized trials","volume":"24","author":"Green","year":"2002","journal-title":"Epidemiologic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub4-BIB70|cit70","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1002\/bjs.6558","article-title":"Assessment of risk of bias in randomized clinical trials in surgery","volume":"96","author":"Gurusamy","year":"2009","journal-title":"British Journal of Surgery"},{"issue":"7651","key":"10.1002\/14651858.CD002190.pub4-BIB71|cit71","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \"quality of evidence\" and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub4-BIB72|cit72","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence--study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD002190.pub4-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.jclinepi.2011.06.004","article-title":"GRADE guidelines: 9. Rating up the quality of evidence","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD002190.pub4-BIB74|cit74","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence--indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD002190.pub4-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence-inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD002190.pub4-BIB76|cit76","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence--imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD002190.pub4-BIB77|cit77","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence--publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"12","key":"10.1002\/14651858.CD002190.pub4-BIB78|cit78","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence--imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub4-BIB79|cit79","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jclinepi.2010.09.012","article-title":"GRADE guidelines: 2. Framing the question and deciding on important outcomes","volume":"64","author":"Guyatt","year":"2011","journal-title":"Journal of Clinical Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub4-BIB80|cit80","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1001\/jama.1967.03130190100014","article-title":"Rhinovirus infections in an industrial population II. Characteristics of illness and antibody response","volume":"202","author":"Gwaltney","year":"1967","journal-title":"JAMA"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub4-BIB81|cit81","first-page":"265","article-title":"Virology and immunology of the common cold","volume":"23","author":"Gwaltney","year":"1985","journal-title":"Rhinology"},{"key":"10.1002\/14651858.CD002190.pub4-BIB82|cit82","first-page":"651","article-title":"The common cold","volume-title":"Principles and Practices of Infectious Diseases","author":"Gwaltney","year":"2000"},{"issue":"25","key":"10.1002\/14651858.CD002190.pub4-BIB83|cit83","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJM200106213442507","article-title":"Respiratory syncytial virus and parainfluenza virus","volume":"344","author":"Hall","year":"2001","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002190.pub4-BIB84|cit84","volume-title":"Harrison Principios de Medicina Interna","author":"Fauci","year":"2008"},{"issue":"9351","key":"10.1002\/14651858.CD002190.pub4-BIB85|cit85","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(03)12162-9","article-title":"The common cold","volume":"361","author":"Heikkinen","year":"2003","journal-title":"Lancet"},{"issue":"5","key":"10.1002\/14651858.CD002190.pub4-BIB86|cit86","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1093\/clinids\/18.5.770","article-title":"Epidemiology and cost of infection with human parainfluenza viruses types 1 and 2 in young children","volume":"18","author":"Henrickson","year":"1994","journal-title":"Clinical Infectious Diseases"},{"issue":"2","key":"10.1002\/14651858.CD002190.pub4-BIB87|cit87","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1128\/CMR.16.2.242-264.2003","article-title":"Parainfluenza viruses","volume":"16","author":"Henrickson","year":"2003","journal-title":"Clinical Microbiology Reviews"},{"key":"10.1002\/14651858.CD002190.pub4-BIB88|cit88","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration Available from www.cochrane-handbook.org 2011"},{"issue":"11","key":"10.1002\/14651858.CD002190.pub4-BIB89|cit89","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.4049\/jimmunol.161.11.6215","article-title":"Host genetic determinants of vaccine-induced eosinophilia during RSV infection","volume":"161","author":"Hussell","year":"1998","journal-title":"Journal of Immunology"},{"issue":"10","key":"10.1002\/14651858.CD002190.pub4-BIB90|cit90","doi-asserted-by":"crossref","first-page":"781","DOI":"10.7326\/0003-4819-141-10-200411160-00009","article-title":"Better reporting of harms in randomized trials: an extension of the CONSORT statement","volume":"141","author":"Ioannidis","year":"2004","journal-title":"Annals of Internal Medicine"},{"issue":"5","key":"10.1002\/14651858.CD002190.pub4-BIB91|cit91","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/EDE.0b013e31818131e7","article-title":"Why most discovered true associations are inflated","volume":"19","author":"Ioannidis","year":"2008","journal-title":"Epidemiology"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub4-BIB92|cit92","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1053\/j.seminhematol.2008.04.010","article-title":"Perfect study, poor evidence: interpretation of biases preceding study design","volume":"45","author":"Ioannidis","year":"2008","journal-title":"Seminars in Hematology"},{"issue":"3-4","key":"10.1002\/14651858.CD002190.pub4-BIB93|cit93","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jrsm.19","article-title":"Meta-research: the art of getting it wrong","volume":"1","author":"Ioannidis","year":"2010","journal-title":"Research Synthesis Methods"},{"issue":"7","key":"10.1002\/14651858.CD002190.pub4-BIB94|cit94","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1164\/rccm.200802-309OC","article-title":"Wheezing rhinovirus illnesses in early life predict asthma development in high-risk children","volume":"178","author":"Jackson","year":"2008","journal-title":"American Journal of Respiratory and Critical Care Medicine"},{"issue":"7","key":"10.1002\/14651858.CD002190.pub4-BIB95|cit95","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006207.pub4","article-title":"Physical interventions to interrupt or reduce the spread of respiratory viruses","author":"Jefferson","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD002190.pub4-BIB96|cit96","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008965.pub3","article-title":"Vaccines for preventing influenza in healthy children","author":"Jefferson","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub4-BIB97|cit97","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00001432-200306000-00012","article-title":"Human metapneumovirus: a newly emerging respiratory pathogen","volume":"16","author":"Kahn","year":"2003","journal-title":"Current Opinion in Infection Diseases"},{"issue":"1","key":"10.1002\/14651858.CD002190.pub4-BIB98|cit98","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10059-009-0015-1","article-title":"Host responses from innate to adaptive immunity after vaccination: molecular and cellular events","volume":"27","author":"Kang","year":"2009","journal-title":"Molecular Cell"},{"issue":"5","key":"10.1002\/14651858.CD002190.pub4-BIB99|cit99","doi-asserted-by":"crossref","first-page":"256","DOI":"10.5694\/j.1326-5377.2002.tb04759.x","article-title":"Determining the sample size in a clinical trial","volume":"177","author":"Kirby","year":"2002","journal-title":"Medical Journal of Australia"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub4-BIB100|cit100","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/00006454-198505000-00009","article-title":"Severe respiratory syncytial virus infection: clinical features, nosocomial acquisition and outcome","volume":"4","author":"Krasinski","year":"1985","journal-title":"Pediatric Infectious Disease"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub4-BIB101|cit101","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jmv.1890050306","article-title":"Isolation of rhinoviruses and coronaviruses from 38 colds in adults","volume":"5","author":"Larson","year":"1980","journal-title":"Journal of Medical Virology"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub4-BIB102|cit102","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1128\/JCM.02614-05","article-title":"Coronavirus HKU1 and other coronavirus infection in Hong Kong","volume":"44","author":"Lau","year":"2006","journal-title":"Journal of Clinical Microbiology"},{"key":"10.1002\/14651858.CD002190.pub4-BIB103|cit103","article-title":"Chapter 6: Searching for studies","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. Available from www.cochrane-handbook.org","author":"Lefebvre","year":"2011"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub4-BIB104|cit104","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jaci.2005.06.024","article-title":"Rhinovirus illnesses during infancy predict subsequent childhood wheezing","volume":"116","author":"Lemanske","year":"2005","journal-title":"Journal of Allergy and Clinical Immunology"},{"issue":"9128","key":"10.1002\/14651858.CD002190.pub4-BIB105|cit105","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD002190.pub4-BIB106|cit106","doi-asserted-by":"crossref","first-page":"c869","DOI":"10.1136\/bmj.c869","article-title":"CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Moher","year":"2010","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD002190.pub4-BIB107|cit107","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1017\/S0950268800050779","article-title":"Acute respiratory illness in the community. Frequency of illness and the agents involved","volume":"110","author":"Monto","year":"1993","journal-title":"Epidemiology and Infection"},{"issue":"2","key":"10.1002\/14651858.CD002190.pub4-BIB108|cit108","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1128\/JCM.36.2.539-542.1998","article-title":"Viruses and bacteria in the etiology of the common cold","volume":"36","author":"M\u00e4kel\u00e4","year":"1998","journal-title":"Journal of Clinical Microbiology"},{"issue":"10","key":"10.1002\/14651858.CD002190.pub4-BIB109|cit109","doi-asserted-by":"crossref","first-page":"795","DOI":"10.7326\/0003-4819-140-10-200405180-00009","article-title":"Clarifying adverse drug events: a clinician's guide to terminology, documentation, and reporting","volume":"140","author":"Nebeker","year":"2004","journal-title":"Annals of Internal Medicine"},{"key":"10.1002\/14651858.CD002190.pub4-BIB110|cit110","article-title":"Nelson Textbook of Pediatrics","volume-title":"Nelson Tratado de Pediatr\u00eda","author":"Robert","year":"2000"},{"issue":"7115","key":"10.1002\/14651858.CD002190.pub4-BIB111|cit111","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1136\/bmj.315.7115.1060","article-title":"Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective population based study of disease burden","volume":"315","author":"Nicholson","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub4-BIB112|cit112","doi-asserted-by":"crossref","first-page":"188","DOI":"10.5694\/j.1326-5377.2002.tb04354.x","article-title":"Evidence of human metapneumovirus in Australian children","volume":"176","author":"Nissen","year":"2002","journal-title":"Medical Journal of Australia"},{"issue":"5923","key":"10.1002\/14651858.CD002190.pub4-BIB113|cit113","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.1165557","article-title":"Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution","volume":"324","author":"Palmemberg","year":"2009","journal-title":"Science"},{"issue":"4","key":"10.1002\/14651858.CD002190.pub4-BIB114|cit114","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jcv.2008.08.014","article-title":"Clinical effects of rhinovirus infections","volume":"43","author":"Peltola","year":"2008","journal-title":"Journal of Clinical Virology"},{"issue":"6","key":"10.1002\/14651858.CD002190.pub4-BIB115|cit115","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1542\/peds.2008-3645","article-title":"Booster vaccinations: can immunologic memory outpace disease pathogenesis?","volume":"124","author":"Pichichero","year":"2009","journal-title":"Pediatrics"},{"issue":"3","key":"10.1002\/14651858.CD002190.pub4-BIB116|cit116","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clinical Infectious Diseases"},{"issue":"21","key":"10.1002\/14651858.CD002190.pub4-BIB117|cit117","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMcibr0902053","article-title":"Common cold, uncommon variation","volume":"360","author":"Poland","year":"2009","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD002190.pub4-BIB118|cit118","doi-asserted-by":"crossref","DOI":"10.1590\/S1135-57272008000400008","volume-title":"Dictionary of Epidemiology","author":"Porta","year":"2008"},{"issue":"2","key":"10.1002\/14651858.CD002190.pub4-BIB119|cit119","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1183\/09031936.00076508","article-title":"Rhinovirus infections in infants: is respiratory syncytial virus ready for the challenge?","volume":"32","author":"Regamey","year":"2008","journal-title":"European Respiratory Journal"},{"issue":"12","key":"10.1002\/14651858.CD002190.pub4-BIB120|cit120","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1086\/524312","article-title":"A recently identified rhinovirus genotype is associated with severe respiratory tract infection in children in Germany","volume":"196","author":"Renwick","year":"2007","journal-title":"Journal of Infectious Diseases"},{"key":"10.1002\/14651858.CD002190.pub4-BIB121|cit121","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2012"},{"key":"10.1002\/14651858.CD002190.pub4-BIB122|cit122","first-page":"2769","article-title":"Human metapneumovirus - occurrence and clinical significance","volume":"20","author":"Risnes","year":"2005","journal-title":"Tidsskrift for den Norske Laegeforening"},{"key":"10.1002\/14651858.CD002190.pub4-BIB123|cit123","article-title":"Glossary","volume-title":"Essential Immunology","volume":"466","author":"Roitt","year":"2004"},{"issue":"1","key":"10.1002\/14651858.CD002190.pub4-BIB124|cit124","first-page":"25","article-title":"Colds and influenza: a review of diagnosis and conventional, botanical and nutritional considerations","volume":"12","author":"Roxas","year":"2007","journal-title":"Alternative Medicine Review"},{"issue":"15","key":"10.1002\/14651858.CD002190.pub4-BIB125|cit125","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1016\/j.vaccine.2005.12.062","article-title":"Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004","volume":"24","author":"Russell","year":"2006","journal-title":"Vaccine"},{"issue":"5","key":"10.1002\/14651858.CD002190.pub4-BIB126|cit126","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD002190.pub4-BIB127|cit127","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1001\/jama.289.2.179","article-title":"Mortality associated with influenza and respiratory syncytial virus in the United States","volume":"289","author":"Thompson","year":"2003","journal-title":"JAMA"},{"issue":"49","key":"10.1002\/14651858.CD002190.pub4-BIB128|cit128","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1016\/j.vaccine.2008.09.080","article-title":"Deceptive imprinting and immune refocusing in vaccine design","volume":"26","author":"Tobin","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1002\/14651858.CD002190.pub4-BIB129|cit129","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejim.2004.01.006","article-title":"The common cold: a review of the literature","volume":"15","author":"Wat","year":"2004","journal-title":"European Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD002190.pub4-BIB130|cit130","unstructured":"Zavala D Marti A Pe\u00f1a-Marti G Comuni\u00e1n G Sheet to enter data for performing a Cochrane review http:\/\/www.cochrane.fcs.uc.edu.ve\/hrs 2006"}],"updated-by":[{"DOI":"10.1002\/14651858.cd002190.pub5","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,5,18]],"date-time":"2017-05-18T00:00:00Z","timestamp":1495065600000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD002190.pub4\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,2]],"date-time":"2023-07-02T06:04:07Z","timestamp":1688277847000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD002190.pub4"}},"subtitle":[],"editor":[{"given":"Daniel","family":"Simancas-Racines","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,6,12]]},"references-count":130,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd002190.pub4","relation":{},"subject":[],"published":{"date-parts":[[2013,6,12]]}}}